Frederico Bastos Gonçalves
@frederico_bg
Followers
219
Following
1K
Statuses
285
RT @EJVES_ESVS: Don't miss this #EJVESVA of the 'UK- COMPASS Study: Perioperative and Midterm Outcomes' @ComplexAAAStudy @VallabhaneniRao @…
0
20
0
RT @acv_journal: 70-year-old, female went to ED with acute abdominal pain, diarrhea and hematemesis. she was haemodinamic unstable and upp…
0
1
0
RT @EJVES_ESVS: Don't miss this month's #EJVESECs 🧵!! 1 - The UK COMPlex AneurySm Study (UK- COMPASS) 2 - Radiation dose reduction during…
0
8
0
RT @vascularis: Fresh from @EJVES_ESVS #EJVESforum - are you using #heparin when managing ruptured #aneurysm "Impact of Intra-Operative He…
0
5
0
RT @acv_journal: Have you seriously thought about giving up your residency program? 1/3 of Portuguese Vascular Residents answered YES Read…
0
1
0
RT @Jonnyboyle1: @EJVES_ESVS @ESVSmembership #AAA Guidelines committee presenting updated 2024 Guidelines #ESVS2023 @IVanherzeele @…
0
11
0
@acv_journal @SPACV_ @EJVES_ESVS @EVST_ESVS @VascularSVS A lot can be said about this: Coral certainly changed my practice but I still perform renal stenting in selected cases. Multidisciplinary decisions are key for success/avoiding harm. Any role for distal protection devices IYO?
0
0
0
RT @acv_journal: Did the CORAL trial impact your clinical practice? State your opinion below ! #CORALtrial #Renalstenosis #Renalstenting #R…
0
1
0
RT @acv_journal: What do you think about the "Octopus Technique"? When and how do you use it? Check it out at Stat…
0
1
0
Some days are special! Congratulations Nelson Gomes Oliveira, PhD
3
0
13
RT @vascularis: Great to see this - the continued strong position of @EJVES_ESVS and the rise of #EJVESforum - all made possible by the #EJ…
0
1
0
@XavierBerardMD @JVascSurgCIT @CHUBordeaux @academicaorta @VascularSVS Thank you Xavier! Beautiful tutorial
0
0
1
José Daniel Menezes 1953-2023 Today, Vascular Surgery has become poorer - and I lost a dear friend, one of the kindest persons I ever met. We will miss him dearly
3
1
7
Very important update, including the new 2023 ESVS Carotid GL app! Don’t miss it!
The #ESVSGuidelines App - Have you updated it recently? The recent #ESVS Clinical Practice #Guidelines on The Management of Atherosclerotic Carotid and Vertebral Artery Disease is now on the app! 📲 Great way to read the most recent recommendations on the go. @arossnaylor
0
3
6
Just off the press! On my way to celebrate the 50th Anniversary of the Vascular Surgery Department of Hospital de Santa Marta, Lisbon! 🎉🎊🎉🎊
0
1
9
Disappointing results for REBOA. Although warranting a reflection from vascular surgeons, ⚠️we should not directly extrapolate to rAAA management⚠️especially intra-operative use for both open and EVAR, in unstable patients - different context, and probably different outcomes.
UK-REBOA results: REBOA increased mortality at 90 days and at all interim time points. REBOA increased deaths due to bleeding at 3 hours and 90 days. REBOA substantially delayed time to definitive haemorrhage control. 💢🎈💢 #ccr23
2
2
6
@Jonnyboyle1 @karimbrohi @VSGBI @BSETnews @BSIR_News @EJVES_ESVS I agree Jon but it is important not to extrapolate to rAAA management, especially intra-operative use for both open and EVAR - different context, different expertise and probably different outcomes
1
0
2
Management of type B aortic dissection: Assessing paradigm shifts and the impact of endovascular technology comment on: Interesting findings - is there still a role for open surgery in acute type B?
0
0
1
0
8
0
What is your take on late complications and surveillance after EVAR? Thanks to the ESVS for the opportunity to share my views in such great company!
@frederico_bg and Hence Verhagen discuss about the different types of endoleaks and how some of them are ‘wolves in sheep's clothing’.🐑 They also talked about late complications after #EVAR, follow-up strategies and more! 🎙️Listen to the full podcast:
0
3
10